FindTrial
Sign In

A study on efficacy of herbal nutritional supplement in management of hypertension

An Open-label, single center, Non â?? Interventional, Observational Study to Evaluate Efficacy and safety of Herbal nutritional Supplement (Cuminum cyminum, Zingiber officinale, Myristica fragrans, Elettaria cardamomum, Linum usitatissimum, Psidium guajava ,Curcuma longa, Cinnamomum verum, Syzygium aromaticum, Glycyrrhiza glabra, Trigonella foenum-graecum, Foeniculum vulgare, Nigella sativa) in management of hypertension and its associated risk factors

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/04/024646
Enrollment
50
Registered
2020-04-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Diabliss Herbal Solution: 15 ml per day 15 ml of herbal nutritional supplement solution dissolved 1 Liter of water and Patients should take this1 Liter solution in a day: 150 ml just be

Sponsors

DIABLISS PVT LIMITED
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Male and female treatment naïve patients, aged >45 years, with diagnosis of hypertension (DBP 110 mm Hg and SBP >150mm Hg)

Exclusion criteria

Exclusion criteria: Male and female treatment naïve patients, aged <45 years, with diagnosis of hypertension ( <DBP 110 mm Hg and SBP <150mm Hg)

Design outcomes

Primary

MeasureTime frame
efficacy of suppliment in 60 days in hypertesive patients and its management with basic parametersTimepoint: 30 days from the enrollment day—

Secondary

MeasureTime frame
efficacy of suppliment in 60 days in hypertesive patients and its management with parametersTimepoint: 8 60 days from date of enroll ment—

Countries

India

Contacts

Public ContactDr C S Janaki

SANTHIRAM MEDICAL COLLEGE&HOSPITAL

loka.anatomy@yahoo.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026